Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1999-5-6
pubmed:abstractText
The Chinese hamster cell lines E36 and CHOK1 dramatically differ in susceptibility to amphotropic murine leukemia virus (A-MuLV) and gibbon ape leukemia virus (GALV); E36 cells are highly susceptible to both viruses, CHOK1 cells are not. We have previously shown that GALV can infect E36 cells by using both its own receptor, HaPit1, and the A-MuLV receptor, HaPit2. Given that the two cell lines are from the same species, the loss of function of both of these receptors in CHOK1 cells is surprising. Other studies have shown that CHOK1 cells secrete proteins that block A-MuLV entry into CHOK1 as well as E36, suggesting the two A-MuLV receptors are functionally identical. However, CHOK1 conditioned medium does not block GALV entry into E36, indicating the secreted inhibitors do not block HaPit1. HaPit1 and ChoPit1 therefore differ as receptors for GALV; ChoPit1 is either inactivated by secreted factors or intrinsically nonfunctional. To determine why GALV cannot infect CHOK1, we cloned and sequenced ChoPit1 and ChoPit2. ChoPit2 is almost identical to HaPit2, which explains why CHOK1 conditioned medium blocks A-MuLV entry via both receptors. Although ChoPit1 and HaPit1 are 91% identical, a notable difference is at position 550 in the fourth extracellular region, shown by several studies to be crucial for GALV infection. Pit1 and HaPit1 have aspartate at 550, whereas ChoPit1 has threonine at this position. We assessed the significance of this difference for GALV infection by replacing the aspartate 550 in Pit1 with threonine. This single substitution rendered Pit1 nonfunctional for GALV and suggests that threonine at 550 inactivates ChoPit1 as a GALV receptor. Whether native ChoPit1 functions for GALV was determined by interference assays using Lec8, a glycosylation-deficient derivative of CHOK1 that is susceptible to both viruses and that has the same receptors as CHOK1. Unlike with E36, GALV and A-MuLV exhibited reciprocal interference when infecting Lec8, suggesting that they use the same receptor. We conclude both viruses can use ChoPit2 in the absence of the inhibitors secreted by CHOK1 and ChoPit1 is nonfunctional.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-1309898, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-1370096, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-1531369, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-1717711, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-1850008, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-2078500, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-2631796, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-3785217, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-601679, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-6280382, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-7884886, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-7929240, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-7966559, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-7966574, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-7966619, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-7983751, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8041748, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8046392, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8278411, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8289366, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8302848, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8391178, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8394452, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8394458, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8411375, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8411376, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8551566, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-8794342, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-9279382, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-9311908, http://linkedlifedata.com/resource/pubmed/commentcorrection/10074140-9343161
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2916-20
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Gibbon ape leukemia virus receptor functions of type III phosphate transporters from CHOK1 cells are disrupted by two distinct mechanisms.
pubmed:affiliation
Laboratory of Cellular and Molecular Regulation, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA.
pubmed:publicationType
Journal Article